ADAPT I Ltd. - Jun 20, 2025 Form 4 Insider Report for Caris Life Sciences, Inc. (CAI)

Role
10%+ Owner
Signature
ADAPT I Ltd., /s/ J. Russel Denton, Attorney-in-Fact
Stock symbol
CAI
Transactions as of
Jun 20, 2025
Transactions value $
$0
Form type
4
Date filed
6/23/2025, 06:31 PM
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
ADAPT I Ltd. 10%+ Owner C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING ADAPT I Ltd., /s/ J. Russel Denton, Attorney-in-Fact 2025-06-23 0002072411
Carisome I, L.P. 10%+ Owner C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING Carisome I, L.P., /s/ J. Russel Denton, Attorney-in-Fact 2025-06-23 0002072412

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAI Common Stock Conversion of derivative security $0 +3.5M +26.04% $0.00 16.9M Jun 20, 2025 See Footnotes F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAI Series A Preferred Stock Conversion of derivative security -14M -100% 0 Jun 20, 2025 Common Stock 3.5M $0.00 See Footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

ADAPT I Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock.
F2 The Common Stock reported herein includes 8,528,805 shares of Common Stock held of record by ADAPT I Ltd. and 8,414,427 shares of Common Stock held of record by Carisome I, L.P. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. David D. Halbert is the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held of record by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F3 The preferred stock reported herein includes 3,500,003 shares of Common Stock underlying Series A Preferred Stock held of record by ADAPT I Ltd..

Remarks:

David Halbert and Caris Halbert, L.P. are filing a separate Form 4 with respect to the transactions reported herein.